Labisan Cold Sore
NDC Package 72941-932-72

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Labisan Cold Sore is directionsClean the affected area at first sign of tingling, burning sensation, or itching. Marketed by Lupuca Pharma Gmbh, this product is identified by NDC 72941-932 and is authorized under FDA application part347.

Identification & Billing

NDC Package Code
72941-932-72
Package Description
6.7 g in 1 TUBE
Product Code
72941-932
11-Digit Billing Format
72941093272
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Labisan Cold Sore
Dosage Form
-
Usage Information
DirectionsClean the affected area at first sign of tingling, burning sensation, or itching. Apply a small amount of this product to the lips or nose prior to exposure to the sun. In case of cold sore/fever blister indication, apply to area of sensation. Apply up to 4 times a day, and in the evening. Rub in gently. Wash hands before and after applying cream. Do not share product with anyone. Keep out of reach of children. Children under 12 years of age: Consult a physician.

Regulatory & Marketing

Labeler Name
Lupuca Pharma Gmbh
FDA Application #
part347
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
03-07-2019
Listing Expiration
12-31-2020
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72941-932-72 identifies a specific commercial package of 6.7 g in 1 tube of Labisan Cold Sore, labeled by Lupuca Pharma Gmbh. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Lupuca Pharma Gmbh on March 07, 2019. The current certification is valid through December 31, 2020.

How is this Lupuca Pharma Gmbh product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72941093272. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72941-932-72
11-Digit CMS (5-4-2)
72941-0932-72

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.